title: Prevention of venous thromboembolism with enoxaparin in bariatirc surgery.
abstract: OBJECTIVE
  Venous thromboembolism (VTE) after bariatric surgery is a significant cause of morbidity and mortality. Current modalities of thromboprophylaxis include subcutaneous injection of unfractionated or low-molecular-weight heparin (LMWH), pneumatic compression, elastic stockings, and inferior vena cava filters. Despite universal agreement on the need for thromboprophylaxis, no clear consensus has been reached regarding the best regimen and treatment duration of bariatric surgery.
  
  
  METHODS
  From April, 2009 to December, 2011, we performed 200 bariatric surgery (191 with primary intent, 9 with revisional intent). There was no history of VTE prior to surgery. Clexane therapy was done with 4000 U SQ once daily for 2 weeks to the day before surgery. Development of VTE was assessed by direct interview, physical examination in out-patient clinic, and phone calls to patients for history taking if needed. The history taking was presented in questionnaire format. The patients were asked to state their symptoms of VTE by answering the questionnaire. The patients were followed up for a minimum of 6 months after surgery to determine the incidence of clinical VTE.
  
  
  RESULTS
  Two-week Clexane therapy was completed in 193 patients. Clexane was stopped in 5 due to surgical related complications (4 bleeding, 1 reoperation due to leak), in 2 due to Clexane related complications (1 epistaxis, 1 metrorrhagia). Follow-up of out-patient clinic were 68%, those who could follow up by telephone were 89%. There was no evidence of VTE.
  
  
  CONCLUSIONS
  A 2-week VTE prophylaxis regimen using LMWH is simple, effective and associated with a low incidence of complications.
authors: Department of Surgery, Soonchunhyang University College of Medicine, Seoul, Korea.
authors: Hee Doo
authors: HD
authors: Woo
authors: Yong Jin
authors: YJ
authors: Kim
keywords: Bariatric surgery; Low-molecular-weight heparin; Venous thromboembolism
references: Minerva Chir. 2005 Oct;60(5):391-9
references: 16210988
references: Surg Obes Relat Dis. 2013 Jan-Feb;9(1):88-93
references: 22055389
references: Adv Hematol. 2012;2012:856341
references: 22496694
references: World J Surg. 2002 Apr;26(4):470-3
references: 11910482
references: Surg Obes Relat Dis. 2010 May-Jun;6(3):322-5
references: 20510295
references: Obes Surg. 2000 Feb;10(1):7-13; discussion 14
references: 10715636
references: Surg Endosc. 2008 Nov;22(11):2384-91
references: 18622558
references: Obes Surg. 2005 Nov-Dec;15(10):1368-74
references: 16354513
references: Thromb Res. 2005;116(1):41-50
references: 15850607
references: Curr Opin Anaesthesiol. 2011 Apr;24(2):166-70
references: 21252650
references: Surg Obes Relat Dis. 2009 May-Jun;5(3):352-6
references: 19342305
references: Chest. 2004 Sep;126(3 Suppl):188S-203S
references: 15383472
references: Obes Surg. 2002 Feb;12(1):19-24
references: 11868291
references: Obes Surg. 2006 Dec;16(12):1645-55
references: 17217642
references: Surg Endosc. 2004 Jul;18(7):1082-4
references: 15156394
references: Obes Surg. 2001 Dec;11(6):670-6
references: 11775562
references: Br J Surg. 2003 May;90(5):547-8
references: 12734859
references: Obes Surg. 2003 Dec;13(6):819-25
references: 14738663
references: N Engl J Med. 2002 Mar 28;346(13):975-80
references: 11919306
references: Chest. 2008 Jun;133(6 Suppl):381S-453S
references: 18574271
references: Obes Surg. 2008 Jul;18(7):791-6
references: 18386108